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Objectives: The function of Kv4.3 (KCND3) channels, which underlie the transient outward current Ito in human heart, can be modulated by
several accessory subunits such as KChIP2 and KCNE1–KCNE5. Here we aimed to determine the regional expression of Kv4.3, KChIP2,
and KCNE mRNAs in non-failing and failing human hearts and to investigate the functional consequences of subunit coexpression in
heterologous expression systems.
Methods: We quantified mRNA levels for two Kv4.3 isoforms, Kv4.3-S and Kv4.3-L, and for KChIP2 as well as KCNE1–KCNE5 with real-
time RT-PCR. We also studied the effects of KCNEs on Kv4.3+KChIP2 current characteristics in CHO cells with the whole-cell voltage-clamp
method.
Results: In non-failing hearts, low expression was found for KCNE1, KCNE3, and KCNE5, three times higher expression for KCNE2, and 60
times higher for KCNE4. Transmural gradients were detected only for KChIP2 in left and right ventricles. Compared to non-failing tissue, failing
hearts showed higher expression of Kv4.3-L and KCNE1 and lower of Kv4.3-S, KChIP2, KCNE4, and KCNE5. In CHO cells, Kv4.3+KChIP2
currents were differentially modified by co-expressed KCNEs: time constants of inactivation were shorter with KCNE1 and KCNE3-5 while
time-to-peak was decreased, and V0.5 of steady-state inactivation was shifted to more negative potentials by all KCNE subunits. Importantly,
KCNE2 induced a unique and prominent 'overshoot' of peak current during recovery from inactivation similar to that described for human Ito
while other KCNE subunits induced little (KCNE4,5) or no overshoot.
Conclusions: All KCNEs are expressed in the human heart at the transcript level. Compared to Ito in native human myocytes, none of the
combination of KChIP2 and KCNE produced an ideal congruency in current characteristics, suggesting that additional factors contribute to
the regulation of the native Ito channel.
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The transient outward current (Ito) determines the early
repolarization phase of cardiac action potential and thus
contributes to the determination of the repolarization phase as
well as excitation–contraction coupling via modulating Ca2+
and other K+ currents [1,24]. In human ventricle Kv4.3d by Elsevier B.V. All rights reserved.
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short and long splice variants (Kv4.3-S and Kv4.3-L) were
detected [10,14]. The electrophysiological properties of Ito are
modulated by several β-subunits [9] among them KChIP2
(K+-channel interacting protein) is the most thoroughly
investigated. KChIP2 increases peak Ito current density by
promoting trafficking of Kv4.3 to the cell membrane [2], slows
inactivation, and accelerates recovery from inactivation [8,23].
KCNE1 (minK) is the major accessory subunit of the
KvLQT1 (KCNQ1) channel forming the slow delayed rectifier
current IKs [5]. KCNE2 encoding for MinK-related peptide 1
(MiRP1) is also expressed in human myocardium [12] and
associates with the cardiac Kv4.3 protein [1]. Kv4.3 has been
shown to be modulated by KCNE1 and KCNE2 in hetero-
logous systems [9]. However, the kinetic properties of native
Ito in human ventricular myocytes can not be properly
explained by Kv4.3 interaction with KChIP2, KCNE2 or
KCNE1 [9]. Other accessory β-subunits with accelerating
effects on the Ito current kinetics may contribute to the cha-
racteristics of Ito. One potential candidate is the dipeptidyl-
aminopeptidase-like protein (DPP6), which has been recently
identified in neuronal and heart tissue and can substantially
accelerate the inactivation of transient K+ currents [19,21].
Furthermore, KCNE3, KCNE4 and KCNE5 exhibit pro-
nounced and distinct effects on important potassium channel
β-subunits such asKCNQ1 andHERG [3,17]. It is conceivable
that these promiscuous KCNE proteins also interact with
Kv4.3 and influence expression and kinetics of Ito.
Native Ito exhibits a characteristic transmural gradient in
ventricles, with larger Ito density in epicardium than in
endocardium [18,27]. In human and dog hearts, this Ito
gradient is believed to be determined by differential KChIP2
expression [22], although there is no consensus on this point
[8]. In failing myocardium Ito is reduced in epicardial as well
as endocardial tissue layers [13,18,27], and this is correlatedTable 1
Primers and conditions for PCR
Gene Acc.-No. Primer Sequence (5′-3′)
Kv4.3-L AF205857 S:TCC ACC ATC AAG AAC CAC G
A:AGC AGG TGG TAG TGA GGC C
Kv4.3-S AF205856 S:GGA AAA AAC CAC TAA CCA CGA GT
A:AGC AGG TGG TAG TGA GGC C A GT
KChIP2 AF199598 S:ATG CTT GAC ATC ATG AAG TCC GT
A:TTG ACA AGA CTC AAT GAATTC GT
KCNE1 BC036452 S:CAC ACA ATC ATC AGG TGA GCC GAG
A.ATG TTG CCA CCC TGC TGA ACT GTC
KCNE2 AF302095 S:CAC ACA CTG CAT AGC AGG AGT GTC
A:AGG ATG GCC ACG ATG ATG AAT GTC
KCNE3 NM005472 S:GTC TGA GCT TCT ACC GAG TCT TCC
A:CTC GTG TTA GAT CAT AGA CAC ACG G
KCNE4 NM080671 S:AAG AGG CGG GAG AAG AAG TCC ACG
A:CCC TGATGC TGA ACATGC TCC ACG G
KCNE5 NM012282 S:CCC CTA CCC CGC ACATCC TCC ACG G
A:TTG GAC GTG TTG GAT TCA GTT CCG G
T7 A32834 S:TAA TAC GAC TCA CTA TAG GGC GGC C
The table specifies sense (S) and antisense (A) primers and reaction conditions u
annealing temperature.with a reduction of Kv4.3 mRNA [13]. Little is known about
the influence of heart failure on the expression of KChIP2, or
other putative Ito β-subunits.
The aim of the present investigation was to quantify the
mRNA levels of Itoα-subunit isoforms, Kv4.3-L and Kv4.3-S,
and putative accessory β-subunits KCNE1–KCNE5 and
KChIP2 in human non-failing and failing ventricles using
the real-time RT-PCR technique. Our main finding is that the
expression ofα- and β-subunits was differentially regulated in
failing hearts. In functional expression experiments in CHO
cells we found distinct patterns of modulation of Kv4.3
+KChIP2 gating kinetics by KCNE subunits, which suggest
that in addition to Kv4.3+KChIP2 association with KCNE2
and other still not identified subunits or regulators are required
to mimic the native Ito function in human heart.
2. Methods
2.1. Tissue
Tissue samples were collected from explanted hearts of
NYHA IV patients (four male, one female) with DCM with
written consents. Medication included digitoxin, metoprolol
and torasemide. Healthy tissue was derived from five donor
hearts (two male, three female). Biopsies were excised from
the central region of the anterior wall of left (LV) and right
(RV) ventricles, were separated into subepi-(epicardial) and
subendocardial (endocardial) layers and immediately stored
in liquid nitrogen. The study conformed with the Declaration
of Helsinki.
2.2. Molecular biology
Total RNA was isolated using the LiCl-method [25].
Quantitative real-time RT-PCR was performed as describedPosition [bp] Size [bp] TA [°C] MgCl2 [mM]
1507–1525 133 58 2.5
1621–1639
1372–1390 211 63 6.0
1564–1582
547–572 162 58 2.5
687–708
83–106 209 60 2.5
268–291
115–134 229 58 3.0
324–343
147–170 363 54 4.0
485–509
G 270–289 337 54 4.0
385–403
790–806 107 58 3.0
880–896
GC GG 12–40 58 2.5
sed for RT-PCR of α- and β-subunits and cRNA standard generation. TA:
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Kv4.3-L and Kv4.3-S, KChIP2 and KCNE1–KCNE4 were
intron-spanning. KCNE5 primers were modified from
published sequences [16] (Table 1).
2.3. CHO expression system
Chinese hamster ovary (CHO) cell lines stably
transfected with hKv4.3-L or hKv4.3/hKChIP2 were
donated from Sanofi–Aventis (Frankfurt, Germany) and
cultured as described in Ref. [21]. KCNE1-3 and KCNE5
cDNAs were obtained from human ventricle mRNA and
cloned in pIRES2-EGFP (BD Biosciences, Heidelberg,
Germany). pXOOM-KCNE4 was donated from Dr. M.
Grunnet (Copenhagen, Denmark). Both pIRES and
pXOOM plasmids drive cDNA expression under the
control of CMV promoters and use EGFP as a transfection
marker. KCNE1-5 plasmids were transfected using 2.5 μl
of Roti-Fect® transfection reagent (Carl Roth, Karlsruhe,
Germany) and a total amount of 0.5 μg plasmid each.
2.4. Electrophysiological experiments
Whole-cell patch-clamp experiments were performed
using a HEKA-EPC8 amplifier (HEKA Elektronik, Lam-
brecht, Germany). Bath solution contained (in mM): NaCl
150, KCl 5.4, MgCl2 2, CaCl2 1.8, HEPES 10, glucose 11,
pH 7.4. Pipette solution contained (in mM): KCl 40,
potassium aspartate 80, NaCl 8, CaCl2 2, MgATP 5,
EGTA 5, GTP 0.1, HEPES 10, pH 7.4 adjusted with KOH.
Pipette tip resistance was between 2.5 and 3.5 MΩ when
filled with pipette solution.Fig. 1. mRNA expression of Kv4.3, KChIP2 and KCNE in human non-failing
expression. (B) KCNE1–KCNE5 mRNA. Mean values±S.E.M. of mRNA ([fg] oThe holding potential was −80 mV. Currents were
measured with clamp steps between −60 and +60 mV.
Series resistance was compensated up to 85%. Clamp pulse
generation, data collection and analysis were performed with
ISO2 software (MFK, Niedernhausen, Germany). Data were
not corrected for junction potentials which was calculated
with 11 mV for the electrode solution with JPCalc software
(P.H. Barry, Sydney, Australia). All experiments were
performed at room temperature (22 °C).
2.5. Statistics
Results are given as means±S.E.M. Statistical analysis
was performed with Student's t-test or one-way ANOVA
with Bonferroni`s post hoc test (GraphPad Prism software,
V4.1; San Diego, CA). Differences were considered to be
significant if P<0.05.
3. Results
3.1. Differential remodeling of Kv4.3 isoforms and KChIP2
expression in human failing heart
The two isoforms, Kv4.3-S and Kv4.3-L, were homo-
geneously expressed with similar mRNA levels in all regions
of non-failing hearts. In failing heart, their expression was
differentially regulated. While Kv4.3-L was upregulated,
Kv4.3-S was markedly downregulated, so that the long
isoform clearly dominated (Fig. 1A, Table 2). KChIP2
expression showed a steep transmural gradient in non-failing
hearts in both left and right ventricles. In failing hearts
KChIP2 expression was markedly reduced in epicardial(NF) and failing hearts (HF). (A) Kv4.3-L, Kv4.3-S and KChIP2 mRNA
f total isolated RNA [ng]) (⁎P<0.05, ⁎⁎P<0.01, ⁎⁎⁎P<0.001), n=5.
Table 2
Summary of quantitative mRNA expression data in all samples from 5 non-failing and 5 failing hearts
Non-Failing Hearts (n=5) Failing Hearts (n=5)
Right ventricle Left ventricle NF Right ventricle Left ventricle HF
EPI ENDO EPI ENDO Pooled EPI ENDO EPI ENDO Pooled
Kv4.3-S 17.2±7.6 18.7±4.1 21.3±6.8 21.7±5.5 19.7±2.9 4.4±0.9 4.5±0.5 4.2±0.4 5.7±0.9 4.7±0.4
Kv4.3-L 22.0±5.7 26.1±5.7 21.9±5.1 25.2±6.5 23.8±2.7 31.4±2.2 33.3±4.5 31.4±0.5 30.1±1.8 31.6±1.3
KChIP2 21.9±5.4 10.6±4.2 25.2±4.2 6.0±4.2 15.9±2.8 6.9±1.5 4.3±0.6 8.1±2.2 2.2±0.4 5.4±0.8
KCNE1 1.7±0,6 1.5±0.3 1.4± 0.3 2.4±0.5 1.7±0.2 4.4±1.2 4.9±1.4 4.6±0.9 4.8±1.3 4.7±0.5
KCNE2 8.0±1.2 7.2±1.5 4.0±0.6 6.6±1.4 6.5±0.7 5.3±0.1 5.3±4.5 5.4±0.8 5.3±0.4 5.3±0.3
KCNE3 2.2±0.6 3.0±0.5 2.5±0.7 2.4±0.3 2.5±0.3 2.0±0.3 2.5±0.4 1.8±0.3 2.3±0.4 2.2±0.2
KCNE4 114.4±9.6 159.0±19.2 127.9±24.0 109.1±13.7 127.6±8.9 73.2±11.6 69.6±2.0 78.6±6.7 78.9±11.3 75.1±4.1
KCNE5 2.4±0.4 3.4±0.9 2.1±0.2 2.1±0.3 2.5±0.3 1.7±0.2 1.5±0.1 1.4±0.2 1.4±0.1 1.5±0.1
Values are given in fg/ng of total RNA. Mean values±S.E.M. include double or triple (KCNE2) determination for each sample.
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of both left and right ventricles was less, although differences
between pooled data were significant. The transmural
gradient of KChIP2 was preserved in failing hearts although
to a reduced level (Fig. 1A, 2A, Table 2).
3.2. Expression pattern and remodeling of KCNE1–KCNE5
in heart failure
In specimens from non-failing hearts the mRNA expres-
sion of KCNE subunits was substantially smaller by a factor
of 5 to 10 compared to the α-subunit Kv4.3 and KChIP2, with
the exception of KCNE4, the expression of which was 6 timesFig. 2. Regional expression of KChIP2 and KCNE2 mRNA in human heart. K
subepicardial (epi) layers of RVand LV in non-failing (NF) and failing (HF) hearts (
HF. (B) KCNE2 mRNA in epi and endo of RV and LV in NF and HF. Mean valuhigher than for Kv4.3 (Fig. 1, Table 2). The order of ex-
pression level was KCNE4>>Kv4.3-L∼Kv4.3-S>KCNE2>
KCNE1∼KCNE3∼KCNE5. All KCNE β-subunits, with
the exception of KCNE2, were homogeneously expressed
between the two ventricles of non-failing human hearts. For
KCNE2, we detected a significantly larger expression in
epicardial specimen of the right compared to the left
ventricle (Fig. 2B, Table 2). Unlike expression of KChIP2,
KCNE2 did not exhibit an expression gradient between epi-
and endocardium in right ventricle. In left ventricle KCNE2
expression tended to be smaller in epicardial than endocar-
dial tissue thus exhibiting a transmural gradient opposite in
direction to that of KChIP2.ChIP2 and KCNE2 mRNA was determined in subendocardial (endo) and
n=5). (A) KChIP2 expression in epi and endo layers of RVand LV in NF and
es±S.E.M.
Fig. 3. Effects of KChIP2 and KCNE4 on Kv4.3 currents. Current tracings (initial 300 ms) elicited by test steps (1000 ms) from −80 mV to −40, −20, 0,+20,+40
and +60 mV in CHO cells stably expressing (A) Kv4.3-L+KCNE4, (B) Kv4.3-L+KChIP2 (C) Kv4.3-L+KChIP2+KCNE4, (D) normalized currents at
+50 mV to compare rate of inactivation.
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KCNEs were differentially altered. While expression of
KCNE1 was significantly larger, that of KCNE4 and KCNE5
was lower compared to non-failing hearts. For KCNE2 and
KCNE3, the mRNA levels were not different in non-failing
and failing hearts (Fig. 1B, Table 2).
3.3. Effects of KCNE1–KCNE5 on Kv4.3+KChIP2 stably
expressed in CHO cells
3.3.1. Current density and current-voltage relations
None of the 5 KCNE subunits was able to produce
membrane currents when co-expressed with Kv4.3-L alone
(Fig. 3A). Only in combination with KChIP2, expression of
Kv4.3-L led to prominent transient outward currents (Fig. 3
B). KChIP2 is an obligatory accessory subunit of native Ito
channels in the heart [15]. Therefore, Kv4.3-L+KChIP2Table 3
Electrophysiological parameters of Ito at room temperature in CHO cells and hum
Ito channel subunits Im (pA/pF)
+50 mV
n Activation
TtP (ms)
n Inactivation
τ (ms)
Kv4.3/KChIP2 303±54 34 7.3±0.4 12 56±3
Kv4.3/KChIP2/KCNE1 310±42 12 4.4±0.4 11 45±5
Kv4.3/KChIP2/KCNE2 199±49 16 3.6±0.2 10 60±6
Kv4.3/KChIP2/KCNE3 234±46 17 4.0±0.3 12 33±3
Kv4.3/KChIP2/KCNE4 311±44 18 2.8±0.2 11 21±2
Kv4.3/KChIP2/KCNE5 279±65 16 2.9±0.2 11 32±2
Kv4.3/KChIP2/KCNE2/KCNE4 225±71 12 5.5±0.5 12 45±6
Human vent. myocytes [27] 54±3
The highlighted values show the closest congruency with data from human. Over
n⁎ number of cells producing “overshoot”.stably expressed in CHO cells served as control, and KCNE
subunits were transiently co-expressed to test their effects
on the Ito kinetics. Kv4.3-L+KChIP2 had an average peak
outward current density of 303±54 pA/pF (+50 mV,
n=34). In the presence of KCNE subunits, current
densities were not significantly altered (Table 3).
3.3.2. Time course of activation and inactivation
All KCNE subunits accelerated the time course of
activation, as indicated by the reduction in time-to-peak
current by about 50% (Fig. 4A). The smallest effect was
detected with the combined expression of KCNE2 plus
KCNE4. The time course of Ito inactivation, which could be
best described by a two-exponential function, was also
affected by KCNEs. KCNE3, KCNE4 and KCNE5
significantly reduced the fast time constant of inactivation.
KCNE4 and KCNE5 also markedly reduced the slow timean ventricular myocytes
n SS-Activ.
V0,5 (mV)
n SS-Inactiv.
V0,5 (mV)
n Recovery
τfast (ms)
n Overshoot
amplitude
n⁎
(H.P.-80 mV)
21 6±2 34 −26±3 30 53±7 26 0.09±0.03 20
15 −1±2 12 −39±2 12 65±10 9 0 0
19 7±4 16 −36±1 18 90±12 17 0.27±0.05 11
21 8±3 16 −43±2 19 89±13 13 0.09 2
17 11±2 18 −34±3 14 38±4 11 0.12±0.02 8
17 4±3 14 −41±3 15 61±10 10 0.15±0.03 9
12 9±2 11 −29±2 11 98±19 10 0.23±0.07 8
5 2±3 4 −46±1 5 24±3 6 0.31±0.07 6
shoot is expressed as amplitude of descending term of function for data fit.
Fig. 4. Effects of KCNE1–KCNE5 (E1–E5) on Kv4.3+KChIP2 current activation and inactivation. (A) Time course of activation is characterized by time to
reach peak current (ms). Inset: tracings of current activation for Kv4.3+KChip2 and Kv4.3+KChip2+KCNE4 at +50 mV. (B) Normalized steady-state
activation (gm) curves for Ito calculated from I /V-curves assuming an Erev of −60 mV. (C) Fast time constant of inactivation determined from fitting
biexponential function to individual current traces at +50 mV; (D) Normalized steady-state inactivation (I / Imax) curves for Ito. In panels (B) and (D), mean data
were fitted by Boltzmann functions to estimate half maximum voltage (V0.5, dotted lines). Compare Table 3.
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expression of KCNE4 and KCNE5 resulted in a pronounced
acceleration of the inactivation time-course (shown for
KCNE4 in Fig. 3 C,D; mean data in Fig. 4C, Table 3).
3.3.3. Voltage-dependence of activation and inactivation
The activation curves were calculated from current-voltage
relations assuming a constant reversal potential of −60 mV
[18]. The voltage-dependence of Ito activation was notFig. 5. Effects of KCNEs on the time course of Kv4.3+KChIP2 current recovery
pulse +50 mV, recovery potential −80 mV. Curve fitting to a biexponential function
7 ms for Kv4.3+KChIP2 (n=26), 89±13 ms for Kv4.3-L+KChIP2+KCNE3 (n=
to focus on fast time course of recovery. (B) Same data as in (A) compressed time
Original current traces of Kv4.3-L+KChIP2 and (D) Kv4.3-L+KChIP2+KCNE2markedly altered by co-expression of KCNEs (Fig. 4B,
Table 3). KCNE β-subunits had, however, a more pronounced
impact on the voltage-dependence of Ito current inactivation.
All KCNE β-subunits shifted V0.5 of steady-state inactivation
to more negative membrane potentials (Fig. 4D, Table 3).
3.3.4. Recovery from inactivation
The time course of recovery from inactivation was deter-
mined with a double-pulse protocol starting at −80 mV tofrom inactivation. (A) Time course of recovery from inactivation of Ito, test
[Y=A⁎(1−exp(− t /τfast))+B⁎ exp(− t /τslow)+C] yielded τfast-values of 53±
13), 38±4 ms for Kv4.3-L+KChIP2+KCNE4 (n=11). Expanded time scale
scale focussing on “overshoot” phenomenon. Complete data in Table 3. (C)
during recovery from inactivation.
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5000 ms. KCNE co-expression had differential impacts on
the kinetics of recovery from inactivation. KCNE1, KCNE2,
KCNE3 and KCNE2 plus KCNE4 slowed the time course of
recovery. KCNE4 alone, however, accelerated recovery from
inactivation (Fig. 5, Table 3). In addition KCNE2, KCNE4
and KCNE5 produced a so-called “overshoot” in Ito current
amplitude, a phenomenon described for native Ito in human
ventricular myocytes [27]. The “overshoot” implies that with
recovery intervals up to 1000 ms peak amplitude of Ito was
transiently larger than during the reference pulse, with a
maximum at the recovery interval of 200 ms. The amplitude
of the “overshoot”was largest with KCNE2 and amounted to
about 10% for the reference amplitude. Control cells (Kv4.3
+KChIP2) and cells co-expressing KCNE1 and KCNE3 did
not manifest an “overshoot” during recovery from inactiva-
tion (Fig. 5, Table 3).
3.3.5. Co-expression of the two KCNE subunits KCNE2 plus
KCNE4
Since co-expression of individual KCNE subunits pro-
duced different current characteristics of Ito, we tested whether
a combined expression of KCNE2 (inducing the largest Ito
overshoot) and KCNE4 (having the largest expression among
KCNE subunits) led to a better recapitulation of native Ito
kinetics. With KCNE2 plus KCNE4 the overshoot was
preserved, V0.5 of current inactivation, however, was rather
positive and time constant of recovery was slowed. Thus, the
effects of KCNE2 dominated those of KCNE4.
4. Discussion
4.1. Kv4.3 and KChIP2 as two major components of Ito
channels in human heart
In human heart, Kv4.3 is the major ion conducting α-
subunit underlying the transient outward current. Previous
studies reported a long (Kv4.3-L) and a short isoform
(Kv4.3-S) [15], whose electrophysiological characteristics
are identical [10]. Kv4.3-L possesses 2 additional PKC
phosphorylation sites and represents the isoform which is
susceptible to PKC-dependent reduction in current ampli-
tude via α-adrenoceptor stimulation [20].
In the present study we separately examined the
expression levels of Kv4.3-L and Kv4.3-S in failing and
non-failing hearts, but since we did not have access to a
plasmid for Kv4.3-S, functional aspects of the channel in the
expression system could only be investigated with Kv4.3-L.
This approach can be justified if the identity of Kv4.3-L and
Kv4.3-S with respect to the proposed binding site for
KChIP2 at the N-terminal domain is taken into account. The
2 isoforms also exhibit homology in their transmembrane
and extracellular domains where KCNE2 and other KCNE
subunits are supposed to bind (Tseng, unpublished observa-
tions). Therefore, the interactions with KChIP2 and KCNE
subunits are likely to be similar for both Kv4.3 isoforms.In non-failing hearts, Kv4.3-L and Kv4.3-S are expressed
in similar mRNA quantities with no transmural gradient. In
failing hearts, Kv4.3-L is up-regulated and Kv4.3-S is down-
regulated, leading to a predominant expression of Kv4.3-L.
Nevertheless, the sum of Kv4.3-L and Kv4.3-S is reduced in
failing compared to non-failing hearts, which confirms the
well known heart failure-associated down-regulation of
global Kv4.3 and Ito amplitude [13]. Furthermore, high
plasma concentrations of noradrenaline in chronic heart
failure can stimulate cardiac α-adrenoceptors and activate
PKC. The predominant expression of Kv4.3-L which is
sensitive to PKC phosphorylation (see above) may con-
tribute to reduced Ito function.
KChIP2 is required for proper trafficking of Kv4.3
channels to the cell membrane [2,4,15]. In various expression
systems, i.e. Xenopus oocytes and HEK-293 cells, co-
expression of Kv4.3 with KChIP2 enhances Ito current
density, slows current inactivation and accelerates recovery
from inactivation [8,28]. We could not study an effect of
KChIP2 on Ito kinetics because unlike the other expression
systems, CHO cells did not exhibit Ito when stably transfected
with Kv4.3 only. In any case, co-expression of Kv4.3
+KChIP2 in CHO cells yields current with a time course of
inactivation similar to native cardiac Ito, but markedly slower
recovery from inactivation and steady-state inactivation in a
more positive potential range. These findings suggest that
KChIP2 may not be the only accessory subunit of native Ito in
cardiomyocytes [12], although we cannot exclude that other
regulatory processes may also be involved.
We did not distinguish between various KChIP2 isoforms
[7], because there is no consensus as to which ones are
present in the heart. Nevertheless, we confirm the differential
epi-/endocardial expression of KChIP2, underlying the steep
transmural gradient in Ito [22,23]. In heart failure, KChIP2 is
substantially down-regulated which can further contribute to
the reduced amplitude of Ito [13].
4.2. Role of KCNE subunits in native Ito?
In heterologous expression systems, several putative
accessory proteins such as KCNEs, DPP6, KChAPs, Kvβ,
and even the sodium channel β-subunit NaChβ1 [9] have
been found to modulate the properties of Kv4.3 channels.
Here we have focused on the KCNE-protein family and all
KCNE subunits were detected at the mRNA level in human
heart. At the protein level, only KCNE2 has been
demonstrated in human heart [12].
Depending on the expression system, there have been
conflicting reports as to whether and how KCNE1 can
modulate Kv4.3 or the related Kv4.2 channels. In oocytes,
KCNE1 did not affect Kv4.2 gating kinetics [28]. In
HEK293 cells KCNE1 slowed all kinetic parameters of
Kv4.3 and increased current amplitude [9]. A similar
regulatory role of KCNE1 in human hearts seems unlikely,
since KCNE1 up-regulation in heart failure is accompanied
by a reduction in Ito amplitude instead of the expected
702 S. Radicke et al. / Cardiovascular Research 71 (2006) 695–703increase. Kinetic parameters of Ito in CHO cells co-
expressing the standard combination of Kv4.3+KChIP2
with KCNE1 reveal better congruency with native Ito for
time course of inactivation and steady-state inactivation but
recovery from inactivation is slowed and an “overshoot” is
absent.
KCNE2 is a promiscuous β-subunit and can interact with
several K+ channels (HERG, KCNQ1, KCNQ4, Kv3.4) in
heterologous expression systems [17]. When co-expressed
with Kv4.3 in Xenopus oocytes in the absence of KChIP2,
KCNE2 significantly slows the time course of Ito activation
and inactivation and shifts the voltage dependence of acti-
vation to positive membrane potentials [28]. However, in our
CHO cell expression system KCNE2 appears to have oppo-
site effects. We found that KCNE2 is exceptional because its
co-expression can best reproduce the unique “overshoot”
phenomenon during recovery from inactivation of human left
ventricular epicardial Ito [27], while other KCNE subunits
were either ineffective or induced only a small “overshoot”
(Table 3). Therefore we suggest that KCNE2 could be an
important component of the native Ito channel complex at
least in human epicardial cardiomyocytes [28].
Expression level of KCNE3 in cardiac tissue is low and
may therefore not have a major effect on Ito kinetics in vivo.
KCNE3 induced, however, the largest shift in Ito steady-state
inactivation to negative potentials close to the value reported
for native myocytes. All other kinetic parameters were less
similar to native Ito compared to Kv4.3+KChIP2 alone. In
addition, KCNE3 did not abolish outward rectification of Ito
as described for KCNQ1 [26].
KCNE4 is the most abundant of all KCNE subunits and
even more abundant than the α-subunit Kv4.3 in human
hearts. The former finding confirms recently published data
[6,16] although the absolute amount of mRNA for KCNE4
was lower than in our study. This apparent discrepancy is
probably due to different primers and general PCR
conditions which preclude direct comparison of quantitative
expression data from different groups. Because of its
exceptionally high expression level KCNE4 is likely to
regulate the native Ito. In our experiments KCNE4
accelerated Kv4.3+KChIP2 current inactivation kinetics,
shifted voltage dependence of steady-state inactivation to
more negative membrane potentials and accelerated recovery
from inactivation. Therefore, the properties of the hetero-
logous Ito with KCNE4 as an additional subunit more closely
resemble native Ito.
Expression of KCNE5 is also low and we suggest that
KCNE5 does not have a prominent role in Ito kinetics.
Nevertheless, KCNE5 also yields a rather narrow fit to the
kinetics of native Ito including a small “overshoot” in
recovery from inactivation.
When co-expressing both KCNE2 and KCNE4 with
Kv4.3+KChIP2, the overshoot was still preserved and
inactivation of Ito remained accelerated. On the other hand,
the time course of inactivation is slowed and steady-state
inactivation is shifted to positive values. Therefore, even thecombination of the 2 KCNE subunits with the standard
channel did not provide a perfect match with native Ito.
In failing hearts, the expression of KCNE subunits was
differentially regulated: Expression of KCNE1 was roughly
doubled, that of KCNE2 and KCNE3 remained unchanged,
and expression of KCNE4 and KCNE5 was reduced.
However, despite the failure-associated reduction in absolute
mRNA level, KCNE4 remained the largest of the KCNE
subunits in failing hearts.
4.3. Study limitations
Tissues samples originated from a heterogeneous patient
group. In addition tissue from failing hearts was exposed to
chronic drug therapy. Therefore it cannot be excluded that
part of the differences originate from drug exposure or are
based on differences in the disease state. mRNA content
though determined quantitatively does not necessarily
correlate with the respective protein levels. Since protein
expression has been reported only for KCNE2, it is not
known whether the native KCNE protein levels are
sufficiently high to have an impact on Ito regulation.
The attempt to identify the composition of the native
channel complex by co-expression of putative α- and β-
subunits can only provide incomplete information because
neither the stoichiometry of expressed subunits nor the
effectiveness of the interaction can be controlled. The
similarity in current characteristics compared to native
currents is an indirect indication of subunit interaction and
has to be confirmed by other means such as immunoprecipita-
tion or fluorescence resonance energy transfer between tagged
subunits.
4.4. Conclusion
In the failing heart the changes in the mRNA expression
levels of the α-subunit of Ito and its putative accessory β-
subunits show substantial up-and down-regulation. Assum-
ing that these changes are translated into membrane protein
expression they may contribute to alterations in cardiac
electrophysiology and to risk for arrhythmias of the diseased
heart. KCNEs do not substitute for KChIP2 in promoting
channel trafficking. The heterologous co-expression of
KCNE proteins in CHO cell support the functional
interaction of KCNE β-subunits with Kv4.3 in native
myocytes, with KCNE2 and possibly KCNE4 being the
likely candidates.
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